Atlas Trials

Advanced Breast Cancer

241 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Breast Cancer

RecordFirmDate
Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer (NCT00793546)Pfizer2009-02-01
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer (NCT01311037)King Faisal Specialist Hospital & Research Center2009-01-01
HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer (NCT00719875)Yale University2008-12-01
A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer (NCT00717951)Academy Military Medical Science, China2008-05-01
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy (NCT00522457)Neovii Biotech2008-01-01
A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer (NCT00445458)Puma Biotechnology, Inc.2007-09-11
Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer (NCT00496366)Rutgers, The State University of New Jersey2007-07-23
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. (NCT00428220)Pfizer2007-07-01
Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer (NCT00561119)Samsung Medical Center2007-05-01
A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer (NCT00398567)Puma Biotechnology, Inc.2007-04-04
AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer. (NCT00454805)AstraZeneca2007-03-01
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment (NCT00452140)Neovii Biotech2007-03-01
Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer (NCT00562458)AstraZeneca2006-12-01
Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer (NCT00387907)Sanofi2006-10-01
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg (NCT00313170)AstraZeneca2006-05-30
Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women (NCT00322348)AstraZeneca2006-04-01
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg (NCT00305448)AstraZeneca2006-03-01
E3 Breast Cancer Taxotere Combination (NCT00494481)Genzyme, a Sanofi Company2006-01-01
Faslodex Advanced Breast Cancer Local Chinese Study (NCT00327769)AstraZeneca2005-11-01
A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014) (NCT00106145)Merck Sharp & Dohme LLC2005-04-01
Faslodex 500mg Multiple Dose Tolerability Study in BC Patients (NCT00328120)AstraZeneca2004-04-01
Second Line Breast Cancer Trial (NCT00635713)AstraZeneca1997-05-01
← Previous Next →

Track Advanced Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.